Joint action on support to coordinated and expedited assessment of clinical trials for COVID-19 therapeutics holds an information session for CTR stakeholders to inform and clarify any question before its start.
Program
| 10-10.15 h: | Introduction of the Joint Action EU4 Health CT Cure : Expedited assessment of COVID 19 therapeutics. Edit Szepessi ( European Commission DG Health and Food safety, Pharmaceuticals , Policy officer ) |
| 10.15h-10.30 h: | Highlights of the project EU4 Health CT Cure : Team members , Structure , Deliverables. Greet Musch ( Federal Agency for Medicinal and Health Products , General Director Pre-authorisation) |
| 10.30h-11h: | Best Practice Guide for expedited assessment of multi-national COVID 19 therapeutic trials. Ann Marie Janson Lang ( Swedish Medicinal Product Agency , Co-Chair CTFG) |
| 11h-11.45h: | Questions and Answers |
| 11.45h-12h | Wrap up and close of the meeting. Edit Szepessi ( European Commission DG Health and Food safety, Pharmaceuticals , Policy officer) |